Neurocrine Biosciences, announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an...
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
Medicines, including insulin, to be available in 40 lower-income countries
Investment fund established to help create sustainable health systems
Announcements...
